AstraZeneca PLC Files 6-K Report
Ticker: AZN · Form: 6-K · Filed: Oct 1, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-issuer, routine-report
Related Tickers: AZN
TL;DR
AZN filed a routine 6-K, confirming 20-F reporting for October 2025.
AI Summary
AstraZeneca PLC filed a Form 6-K on October 1, 2025, reporting as a foreign issuer. The filing indicates that AstraZeneca is submitting its reports under Form 20-F, which is typical for companies incorporated outside the US. The report covers the month of October 2025 and provides standard company information.
Why It Matters
This filing is a routine disclosure for foreign issuers like AstraZeneca, providing standard updates to the SEC and investors about their reporting status.
Risk Assessment
Risk Level: low — This is a standard, routine filing for a foreign issuer and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the 6-K report
- 001-11960 (company) — SEC File Number for AstraZeneca PLC
- 1 Francis Crick Avenue (company) — Business and mailing address of AstraZeneca PLC
- Cambridge Biomedical Campus (company) — Business and mailing address of AstraZeneca PLC
- CB2 0AA (company) — ZIP code for AstraZeneca PLC's address
- 011 44 20 7304 5000 (company) — Business phone number for AstraZeneca PLC
- ZENECA GROUP PLC (company) — Former company name of AstraZeneca PLC
- 19930422 (company) — Date of name change from ZENECA GROUP PLC
FAQ
What type of report is AstraZeneca PLC filing?
AstraZeneca PLC is filing a Form 6-K, which is a Report of Foreign Issuer.
What period does this Form 6-K cover?
This Form 6-K is for the month of October 2025.
What is AstraZeneca PLC's SEC file number?
AstraZeneca PLC's SEC file number is 001-11960.
Does AstraZeneca PLC file annual reports under Form 20-F or 40-F?
The filing indicates that AstraZeneca PLC files annual reports under Form 20-F.
Where is AstraZeneca PLC's principal executive office located?
AstraZeneca PLC's principal executive office is located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 14.7 · Accepted 2025-10-01 10:19:19
Key Financial Figures
- $0.25 — s is 1,550,701,945 ordinary shares of US$0.25. No shares are held in Treasury. Theref
Filing Documents
- a5115b.htm (6-K) — 18KB
- 0001654954-25-011310.txt ( ) — 20KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 01 October 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary